In this five-part series, Dr. Eeckman looks at technological advances that have given rise to broad avenues for drug research. Here, in Part 5, he discusses the companies doing stem cell work. Part 5A covered the first five companies in the field; here we look at the second batch of biotech firms, including ReNeuron, NsGene, Cellartis and Layton Bioscience, discussing their individual approaches to this wide-open field...
